Back to results
US 2026/0060985 A1Published application
Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof
AssigneeGalectin Sciences, LLC
InventorsRaphael Nir, Eliezer Zomer, Peter G. Traber, Joseph M. Johnson, Ryan George, Sharon Shechter
Life of this patent
Estimating the term…
Abstract
Aspects of the invention relate to compounds, pharmaceutical compositions, methods for the manufacturing of compounds and methods for treatment of various disorders mediated at least in part by one or more galectins.
Claims20
A compound of Formula I or a pharmaceutically acceptable salt or solvate thereof:
- Formula I:
- wherein Y linkage is (—CH═) or (—CH2-) or —CH2-X— wherein X is nitrogen, oxygen, sulfur or selenium;
- wherein Z is a carbon, or a heteroatom, wherein the heteroatom is nitrogen, oxygen, sulphur, or selenium;
- wherein R1 is hydrogen, oxygen, amine, carboxyl, C1-C6 alkyl, C1-C4 alkoxy, aryl, halogen, trifluoromethyl, dinitromethyl or a combination of the foregoing;
- and
- wherein R2 and R3 are independently selected from the group consisting of hydrogen, hydroxyl, amine, carboxyl, C1-C6 alkyl, C1-C4 alkoxy, and halogen.
3 more elements
A compound of Formula II or a pharmaceutically acceptable salt or solvate thereof:
- Formula II:
- wherein A-M is a 2 atoms linkage having the structure of an amide —N(—Ra)—C(═O)—, sulfonamide —N(—H)—S(═O2)-, a methylether —C(—H2)-O—, methylester —C(═O)—O—, carbosulfon —C(—H2)—S(═O)(═O)—, phosphate —O—P(═O)(—OH)—, diphosphate —O—P(═O)(—O)—O—P(═O)(—O)—, Hydrazide —N(—H)—N(—H)—, selanomethylene, ethylene, or glycol,
- wherein linkage (Y) is (—CH═) or (—CH2-) or —CH2-X—,
- wherein X is nitrogen, oxygen, sulfur or selenium;
- wherein Z is a carbon, or a heteroatom wherein the heteroatom is nitrogen, oxygen sulphur, or selenium;
- wherein R1 is hydrogen, oxygen, amine, carboxyl, C1-C6 alkyl, C1-C4 alkoxy, aryl, halogen, trifluoromethyl, dinitromethyl or a combination of the foregoing;
- and
- wherein R2 and R3 are independently selected from the group consisting of hydrogen, hydroxyl, amine, C1-C6 alkyl, C1-C4 alkoxy, and halogen;
- or wherein R2, R3 or R2 and R3 are aryl group with one or more substitutions, wherein the one or more substitutions is hydroxyl, amine, C1-C6 alkyl, C1-C4 alkoxy, halogen, or benzene;
- or wherein R2, R3 or R2 and R3 are fluoromethyl.
7 more elements
A compound of Formula IV or a pharmaceutically acceptable salt or solvate thereof:
- Formula IV:
- wherein Z is a carbon, or a heteroatom wherein the heteroatom is nitrogen, oxygen Sulphur, or selenium;
- wherein R1, R2, R3 and R4 are independently selected from the group consisting of CO, SO2, SO, PO2, PO, CH, Hydrogen, hydrophobic linear and cyclic hydrocarbons including heterocyclic substitutions of molecular weight of about 10-200 D;
- wherein linkage (Y) is methylidene (—CH═) or methylene (—CH2-)—) or —CH2-X—;
- wherein X is nitrogen, oxygen, sulfur or selenium;
- and
- wherein the A-M linkage being at least 2 atoms linkage having the structure of an amide —N(—Ra)—C(═O)—, sulfonamide —N(—H)—S(═O2)-, a methylether —C(—H2)-O—, methylester —C(═O)—O—, carbosulfon —C(—H2)-S(═O)(═O)—, phosphate —O—P(═O)(—OH)—, diphosphate —O—P(═O)(—O)—O—P(═O)(—O)—, Hydrazide —N(—H)—N(—H)—, selanomethylene, ethylene, or glycol.
4 more elements
Dependencies are inferred from the claim text.